Souders Financial Advisors lifted its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 35.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,190 shares of the financial services provider’s stock after purchasing an additional 2,160 shares during the quarter. Souders Financial Advisors’ holdings in CME Group were worth $1,902,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also made changes to their positions in the stock. Truvestments Capital LLC purchased a new position in CME Group in the third quarter valued at about $26,000. SJS Investment Consulting Inc. increased its stake in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the last quarter. Dunhill Financial LLC lifted its stake in shares of CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners acquired a new stake in shares of CME Group in the 4th quarter valued at $32,000. Finally, Fortitude Family Office LLC boosted its holdings in CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts have weighed in on CME shares. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Oppenheimer boosted their target price on CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Piper Sandler lifted their price target on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. upped their price objective on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $236.13.
Insider Activity
In other news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,076 shares of company stock worth $4,271,496. Corporate insiders own 0.30% of the company’s stock.
CME Group Trading Down 1.9 %
CME Group stock opened at $251.98 on Wednesday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $258.78. The stock has a market cap of $90.80 billion, a price-to-earnings ratio of 26.06, a price-to-earnings-growth ratio of 6.76 and a beta of 0.57. The business has a 50 day moving average price of $239.05 and a two-hundred day moving average price of $229.89. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.98%. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 51.71%.
CME Group announced that its board has approved a share buyback program on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Stock Dividend Cuts Happen Are You Ready?
- GitLab: Get In While It’s Down—Big Rebound Ahead
- What Are Dividend Champions? How to Invest in the Champions
- Tesla Stock: Finding a Bottom May Take Time
- What does consumer price index measure?
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.